US1598641074 - Common Stock
CHARLES RIVER LABORATORIES
NYSE:CRL (3/27/2024, 8:06:55 PM)
After market: 269.37 0 (0%)269.37
+3.93 (+1.48%)
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides research models required in the research and development of new drugs, devices, and therapies. The company is headquartered in Wilmington, Massachusetts and currently employs 20,000 full-time employees. The company went IPO on 2000-06-23. The firm provides research models required in research and development of new drugs, devices, and therapies. The firm operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment includes the research models, research model services, and research and cells solutions businesses. The DSA segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. The Manufacturing segment includes Microbial Solutions and Biologics Solutions (Biologics).
CHARLES RIVER LABORATORIES
251 Ballardvale St
Wilmington MASSACHUSETTS 01887
P: 17812226000
CEO: James C. Foster
Employees: 20000
Website: https://www.criver.com/
Monday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Here you can normally see the latest stock twits on CRL, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: